Kalohexis Announces Poster Presentation at the American Association for Cancer Research Annual Meeting 2026

NORTHBROOK, Ill., April 17, 2026 /PRNewswire/ -- Kalohexis, a clinical-stage biotechnology company harnessing the melanocortin system to shape the next era of metabolic disease care starting with obesity and cancer cachexia, today announced a poster presentation at the American...